TAK logo

TAK Operating Cash Flow (Statement)

Latest reported¥953.63B JPY
TAK Cash from Operations · JPY (¥158.96B → ¥953.63B)
High-resolution chart · PNG

TAK operating cash flow (statement) history

Annual fiscal periods · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Operating Cash Flow (Statement) — Annual fiscal periods (JPY)
Period endingOperating Cash Flow (Statement) (JPY)
1,041,431,000,000
1,057,182,000,000
716,344,000,000
977,156,000,000
1,123,105,000,000
1,010,931,000,000
669,752,000,000
328,479,000,000
377,854,000,000
261,363,000,000
25,491,000,000
182,517,000,000
148,720,000,000
332,579,000,000
336,570,000,000
326,938,000,000
381,168,000,000
326,273,000,000
292,496,000,000
209,280,000,000
373,575,000,000
295,539,000,000
311,122,000,000
263,449,000,000
240,586,000,000
212,662,000,000
158,962,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.